FindTrial
Sign In

Biomarkers in combination with clinical data to develop a prediction model of acute kidney injury after liver transplantation

Biomarkers in combination with clinical data to develop a prediction model of acute kidney injury after liver transplantation

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR1900024561
Enrollment
Unknown
Registered
2019-07-16
Start date
2019-07-31
Completion date
Unknown
Last updated
2019-07-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

acute kidney injury, liver transplantation

Interventions

Gold Standard:Clinical outcome
Index test:combination&#32
biomarkers&#32
for&#32
prediction&#32
model&#32
of&#32
acute&#32
kidney&#32
injury

Sponsors

Beijing You'an Hospital, Capital Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: Aged >= 18 years patients admitted in surgical ICU expected to stay in ICU >=24 hours after liver transplantation for 11 months.

Exclusion criteria

Exclusion criteria: Pregnancy and lactation women, patients with preoperative chronic renal insufficiency uremia period or renal replacement therapy (RRT), liver and kidney transplantation, renal transplantation, living related liver transplantation, into ICU again.

Design outcomes

Primary

MeasureTime frame
Neutrophil gelatinase-associated lipocalin, NGAL;macrophage migration inhibitory factor, MlF;Endostatin;Cystatin C;SEN, SPE, ACC, AUC of ROC;—

Countries

China

Contacts

Public ContactWang Xin

Beijing You'an Hospital, Capital Medical University

wangxin19780530@sina.com+86 13466383116

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026